RE: Conversation with IR......absolutely.
Thanks for sharing that bioboffin....
........."I checked the Elan/Wyeth press release about their phase III to see how their phase II results led to the initiation of the phase III. The press release is below. It provides little detail on the mechanism for determining when/under what circumstances a phase III could be launched, but clearly Elan/Wyeth are launching well before the completion of their phase II and the unblinding of the data."
They sure are moving forward with the Phaselll long before the Phasell Data is Unblinded. Although not detailed to provide a roadmap there are still explainations as to why and how in that news release. Really the only thing it does not say is " The Trial has shown Signs of Efficacy". That conclusion can not be determined until the data is analyzed. The most common mindset in the debate about this is; that the Trial MUST HAVE shown "Signs of Efficacy" to persuade the FDA to grant these actions as well as for Elan/Wyeth to commit hundreds of millions of dollars to a Phaselll. Note disclaimer in NR.
For me as an investor in Transition to hear Dr. Cruz publicly say....."With AZD-103 there is a chance to start a Phaselll while the Phasell is still ongoing if there is any signs of Efficacy".......is enough for me. The Elan/Wyeth debate is no longer a debate for me. The answer has been given and substantiated by Dr. Cruz. As I recall you bioboffin assumed the Phasell was unblinded because of Dr. Cruz's remarks. You heard him say this or something like this too.
The third party peek at efficacy could expedite the process for Transition but seeing that there are so many variables available to the sponsors when designated "Fast Track Status" it may not be in the exact same form as Elan got with aab001...........too many variables to speculate. We do know this however......that whatever action is taken , it is taken to speed up the process to get the Drug to market!!
Keeping with the IR subject.......Email from Damiani yesterday....there will be No Webcast at the RBC Conference this week. He changed the website to reflect this oversight.